Copyright Reports & Markets. All rights reserved.

Impact of COVID-19 Outbreak on Meningococcal Vaccination, Global Market Research Report 2020

Request for Sample of this report
Buy now

1 Meningococcal Vaccination Market Overview

  • 1.1 Product Overview and Scope of Meningococcal Vaccination
  • 1.2 Covid-19 Impact on Meningococcal Vaccination Segment by Type
    • 1.2.1 Global Meningococcal Vaccination Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 Polysaccharide
    • 1.2.3 Conjugate
    • 1.2.4 Combination
  • 1.3 Covid-19 Impact on Meningococcal Vaccination Segment by Application
    • 1.3.1 Meningococcal Vaccination Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 Pneumonia
    • 1.3.3 Meningitis
    • 1.3.4 Bacteremia
    • 1.3.5 Others
  • 1.4 Covid-19 Impact on Global Meningococcal Vaccination Market Size Estimates and Forecasts
    • 1.4.1 Global Meningococcal Vaccination Revenue 2015-2026
    • 1.4.2 Global Meningococcal Vaccination Sales 2015-2026
    • 1.4.3 Meningococcal Vaccination Market Size by Region: 2020 Versus 2026
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Meningococcal Vaccination Industry
  • 1.7 COVID-19 Impact: Meningococcal Vaccination Market Trends

2 Covid-19 Impact on Global Meningococcal Vaccination Market Competition by Manufacturers

  • 2.1 Global Meningococcal Vaccination Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Meningococcal Vaccination Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Meningococcal Vaccination Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Meningococcal Vaccination Manufacturing Sites, Area Served, Product Type
  • 2.5 Meningococcal Vaccination Market Competitive Situation and Trends
    • 2.5.1 Meningococcal Vaccination Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Meningococcal Vaccination Players (Opinion Leaders)

3 Covid-19 Impact on Meningococcal Vaccination Retrospective Market Scenario by Region

  • 3.1 Global Meningococcal Vaccination Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Meningococcal Vaccination Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Meningococcal Vaccination Market Facts & Figures by Country
    • 3.3.1 North America Meningococcal Vaccination Sales by Country
    • 3.3.2 North America Meningococcal Vaccination Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Meningococcal Vaccination Market Facts & Figures by Country
    • 3.4.1 Europe Meningococcal Vaccination Sales by Country
    • 3.4.2 Europe Meningococcal Vaccination Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Meningococcal Vaccination Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Meningococcal Vaccination Sales by Region
    • 3.5.2 Asia Pacific Meningococcal Vaccination Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Meningococcal Vaccination Market Facts & Figures by Country
    • 3.6.1 Latin America Meningococcal Vaccination Sales by Country
    • 3.6.2 Latin America Meningococcal Vaccination Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa Meningococcal Vaccination Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Meningococcal Vaccination Sales by Country
    • 3.7.2 Middle East and Africa Meningococcal Vaccination Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Covid-19 Impact on Global Meningococcal Vaccination Historic Market Analysis by Type

  • 4.1 Global Meningococcal Vaccination Sales Market Share by Type (2015-2020)
  • 4.2 Global Meningococcal Vaccination Revenue Market Share by Type (2015-2020)
  • 4.3 Global Meningococcal Vaccination Price Market Share by Type (2015-2020)
  • 4.4 Global Meningococcal Vaccination Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global Meningococcal Vaccination Historic Market Analysis by Application

  • 5.1 Global Meningococcal Vaccination Sales Market Share by Application (2015-2020)
  • 5.2 Global Meningococcal Vaccination Revenue Market Share by Application (2015-2020)
  • 5.3 Global Meningococcal Vaccination Price by Application (2015-2020)

6 Company Profiles and Key Figures in Meningococcal Vaccination Business

  • 6.1 GlaxoSmithKline
    • 6.1.1 Corporation Information
    • 6.1.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 6.1.3 GlaxoSmithKline Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 GlaxoSmithKline Products Offered
    • 6.1.5 GlaxoSmithKline Recent Development and Response to COVID-19
  • 6.2 JN-International Medical
    • 6.2.1 JN-International Medical Corporation Information
    • 6.2.2 JN-International Medical Description, Business Overview and Total Revenue
    • 6.2.3 JN-International Medical Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 JN-International Medical Products Offered
    • 6.2.5 JN-International Medical Recent Development and Response to COVID-19
  • 6.3 Novartis International
    • 6.3.1 Novartis International Corporation Information
    • 6.3.2 Novartis International Description, Business Overview and Total Revenue
    • 6.3.3 Novartis International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Novartis International Products Offered
    • 6.3.5 Novartis International Recent Development and Response to COVID-19
  • 6.4 Sanofi
    • 6.4.1 Sanofi Corporation Information
    • 6.4.2 Sanofi Description, Business Overview and Total Revenue
    • 6.4.3 Sanofi Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Sanofi Products Offered
    • 6.4.5 Sanofi Recent Development and Response to COVID-19
  • 6.5 Pfizer
    • 6.5.1 Pfizer Corporation Information
    • 6.5.2 Pfizer Description, Business Overview and Total Revenue
    • 6.5.3 Pfizer Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 Pfizer Products Offered
    • 6.5.5 Pfizer Recent Development and Response to COVID-19
  • 6.6 Baxter International
    • 6.6.1 Baxter International Corporation Information
    • 6.6.2 Baxter International Description, Business Overview and Total Revenue
    • 6.6.3 Baxter International Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Baxter International Products Offered
    • 6.6.5 Baxter International Recent Development and Response to COVID-19
  • 6.7 Biomed
    • 6.6.1 Biomed Corporation Information
    • 6.6.2 Biomed Description, Business Overview and Total Revenue
    • 6.6.3 Biomed Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Biomed Products Offered
    • 6.7.5 Biomed Recent Development and Response to COVID-19
  • 6.8 Serum Institute of India
    • 6.8.1 Serum Institute of India Corporation Information
    • 6.8.2 Serum Institute of India Description, Business Overview and Total Revenue
    • 6.8.3 Serum Institute of India Meningococcal Vaccination Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Serum Institute of India Products Offered
    • 6.8.5 Serum Institute of India Recent Development and Response to COVID-19

7 Meningococcal Vaccination Manufacturing Cost Analysis

  • 7.1 Meningococcal Vaccination Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Meningococcal Vaccination
  • 7.4 Meningococcal Vaccination Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Meningococcal Vaccination Distributors List
  • 8.3 Meningococcal Vaccination Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Meningococcal Vaccination Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Meningococcal Vaccination by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Meningococcal Vaccination by Type (2021-2026)
  • 10.2 Meningococcal Vaccination Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Meningococcal Vaccination by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Meningococcal Vaccination by Application (2021-2026)
  • 10.3 Meningococcal Vaccination Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Meningococcal Vaccination by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Meningococcal Vaccination by Region (2021-2026)
  • 10.4 North America Meningococcal Vaccination Estimates and Projections (2021-2026)
  • 10.5 Europe Meningococcal Vaccination Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific Meningococcal Vaccination Estimates and Projections (2021-2026)
  • 10.7 Latin America Meningococcal Vaccination Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa Meningococcal Vaccination Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Meningococcal Vaccination market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Meningococcal Vaccination industry.

    Segment by Type, the Meningococcal Vaccination market is segmented into
    Polysaccharide
    Conjugate
    Combination

    Segment by Application
    Pneumonia
    Meningitis
    Bacteremia
    Others

    Global Meningococcal Vaccination Market: Regional Analysis
    The Meningococcal Vaccination market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Meningococcal Vaccination market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    Global Meningococcal Vaccination Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Meningococcal Vaccination market include:
    GlaxoSmithKline
    JN-International Medical
    Novartis International
    Sanofi
    Pfizer
    Baxter International
    Biomed
    Serum Institute of India
    Buy now